Physician profile
Ali Husain
NPI 1154525707
$9,149.02
in general payments reported to CMS, 2019-2025
43 companies · $16.46 in 2025
The $16.46 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,958 · 2020: $1,670 · 2021: $1,871 · 2022: $2,020 · 2023: $1,613 · 2025: $16.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,546 · Education: $83.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.17 |
| Education | $83.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,148.07 | 2019-2023 | Breztri, Farxiga |
| Lilly USA, LLC | $1,043.50 | 2019-2023 | Mounjaro, Trulicity |
| Glaxosmithkline, LLC. | $954.22 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $930.15 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $647.29 | 2019-2023 | |
| Novo Nordisk INC | $542.21 | 2019-2023 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $446.43 | 2019-2023 | |
| Pfizer INC. | $437.42 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $426.02 | 2019-2023 | Synjardy, Jardiance |
| Janssen Pharmaceuticals, INC | $320.72 | 2019-2023 | Xarelto |
| Corcept Therapeutics | $269.69 | 2021-2023 | Korlym |
| Grifols USA, LLC | $192.68 | 2019 | |
| Sunovion Pharmaceuticals INC. | $190.91 | 2019-2022 | |
| Astellas Pharma US INC | $153.82 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $148.80 | 2020-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Husain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.